$3.29
At close: Apr 2, 3:30 PM EDT
Comments
Loading...
HLS Therapeutics Stock Guidance | OTC:HLTRF | Benzinga
HLS Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLS Therapeutics Inc (HLTRF) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for HLS Therapeutics (HLTRF)?
There have been no specific sales or earnings guidance reported for HLS Therapeutics in recent months.
Browse guidance and forecast on all stocks.